Abstract
Inosine is an endogenous nucleoside that has anti-inflammatory and antinociceptive properties. Inosine is a metabolite of adenosine, and some of its actions suggest the involvement of adenosine A1 receptors (A1Rs). The purpose of this study was to better understand mechanisms of inosine-induced antinociception by investigating the role of A1Rs and purine metabolism inhibitors. Inosine antinociception was evaluated using the formalin test in mice. An A1R-selective antagonist (DPCPX), A1R knockout mice (gene deletion) and mice with A1R reduced expression (antisense oligonucleotides) were used to assess the role of A1Rs in the antinociceptive action of inosine. Binding assays were performed to compare the affinity of inosine and adenosine for A1Rs. Finally, the role of adenosine and inosine breakdown was assessed using deoxycoformycin (DCF) and forodesine (FDS) as enzymatic inhibitors of adenosine deaminase and purine nucleoside phosphorylase, respectively. Inosine induced antinociception in the formalin test when given by systemic, spinal and peripheral routes. Systemically, inosine exhibited a potency similar to adenosine, and its effects were inhibited by DPCPX. Inosine did not induce antinociception in A1R knockout mice or in mice with reduced A1R expression. In binding studies, inosine bound to A1Rs with an affinity similar to adenosine. DCF had no effect on inosine actions. FDS augmented the antinociceptive effect of a low systemic dose of inosine and, at a higher dose, induced antinociception by itself. Collectively, these data indicate that inosine is an agonist for A1Rs with antinociceptive properties and a potency similar to adenosine and can be considered another endogenous ligand for this receptor.
Similar content being viewed by others
References
Haskó G, Sitkovsky MV, Szabo C (2004) Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol Sci 25:152–157
Zylka MJ (2011) Pain-relieving prospects for adenosine receptors and ectonucleotidases. Trends Mol Med 17:188–196
Sawynok J, Liu XJ (2003) Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 69:313–340
Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527–552
Nascimento FP, Figueredo SM, Marcon R, Martins DF, Macedo SJ Jr, Lima DA, Almeida RC, Ostroski RM, Rodrigues AL, Santos ARS (2010) Inosine reduces pain-related behavior in mice: involvement of adenosine A1 and A2A receptor subtypes and protein kinase C pathways. J Pharmacol Exp Ther 334:590–598
Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5:247–264
Chen JF, Eltzschig HK, Fredholm BB (2013) Adenosine receptors as drug targets-what are the challenges? Nat Rev Drug Discov 12:265–286
Sawynok J (1998) Adenosine receptor activation and nociception. Eur J Pharmacol 347:1–11
Dickenson AH, Suzuki R, Reeve AJ (2000) Adenosine as a potential analgesic target in inflammatory and neuropathic pains. CNS Drugs 13:77–85
Burnstock G, Sawynok J (2010) Adenosine triphosphate and adenosine receptors and pain. In: Beaulieu P, Lussier D, Porreca F, Dickenson AH (eds) Pharmacology of Pain, IASP Press, 303–326
Haskó G, Kuhel DG, Németh ZH, Mabley JG, Stachlewitz RF, Virág L, Lohinai Z, Southan GJ, Salzman AL, Szabó C (2000) Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J Immunol 164:1013–1019
Garcia Soriano F, Liaudet L, Marton A, Haskó G, Batista Lorigados C, Deitch EA, Szabó C (2001) Inosine improves gut permeability and vascular reactivity in endotoxic shock. Crit Care Med 29:703–708
Marton A, Pacher P, Murthy KG, Németh ZH, Haskó G, Szabó C (2001) Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro. Int J Mol Med 8:617–621
Yamagiwa T, Shimosegawa T, Satoh A, Kimura K, Sakai Y, Masamune A (2004) Inosine alleviates rat caerulein pancreatitis and pancreatitis-associated lung injury. J Gastroenterol 39:41–49
Schneider L, Pietschmann M, Hartwig W, Marcos SS, Hackert T, Gebhard MM, Uhl W, Büchler MW, Werner J (2006) Inosine reduces microcirculatory disturbance and inflammatory organ damage in experimental acute pancreatitis in rats. Am J Surg 191:510–514
Gomez G, Sitkovsky MV (2003) Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood 102:4472–4478
Módis K, Gero D, Nagy N, Szoleczky P, Tóth ZD, Szabó C (2009) Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis. Br J Pharmacol 158:1565–1578
Rahimian R, Fakhfouri G, Daneshmand A, Mohammadi H, Bahremand A, Rasouli MR, Mousavizadeh K, Dehpour AR (2010) Adenosine A2A receptors and uric acid mediate protective effects of inosine against TNBS-induced colitis in rats. Eur J Pharmacol 649:376–381
da Rocha LF, de Oliveira AP, Accetturi BG, de Oliveira MI, Domingos HV, de Almeida CD, de Lima WT, Santos ARS (2013) Anti-inflammatory effects of inosine in allergic lung inflammation in mice: evidence for the participation of adenosine A(2A) and A (3) receptors. Purinergic Signal 9:325–336
Assaife-Lopes N, de Sá Pinheiro AA, Leão-Ferreira LR, Caruso-Neves C (2009) Inhibition of renal Na+-ATPase activity by inosine is mediated by A1 receptor-induced inhibition of the cAMP signaling pathway. Arch Biochem Biophys 489:76–81
Macedo-Junior SJ, Nascimento FP, Luiz-Cerutti M, Santos ARS (2013) Role of pertussis toxin-sensitive G-protein, K+ channels, and voltage-gated Ca2+ channels in the antinociceptive effect of inosine. Purinergic Signal 9:51–58
Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109–110
Liu J, Reid AR, Sawynok J (2013) Spinal serotonin 5-HT7 and adenosine A1 receptors, as well as peripheral adenosine A1 receptors, are involved in antinociception by systemically administered amitriptyline. Eur J Pharmacol 698:213–219
Sawynok J, Reid AR (2012) Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A(1) receptors. Eur J Pharmacol 674:248–254
Biggs TA, Myers RD (1997) Adenosine A1 receptor antisense infused in striatum of rats: actions on alcohol-induced locomotor impairment, blood alcohol, and body temperature. Alcohol 14:617–621
Dutra RC, Cola M, Leite DF, Bento AF, Claudino RF, Nascimento AF, Leal PC, Calixto JB (2011) Inhibitor of PI3Kgamma ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cells. Br J Pharmacol 163:358–374
Sousa VC, Assaife-Lopes N, Ribeiro JA, Pratt JA, Brett RR, Sebastião AM (2011) Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of delta9-tetrahydrocannabinol on spatial memory. Neuropsychopharmacology 36:472–487
Cohen FR, Lazareno S, Birdsall NJ (1996) The affinity of adenosine for the high- and low-affinity states of the human adenosine A1 receptor. Eur J Pharmacol 309:111–114
Liz R, Pereira DF, Horst H, Dalmarco EM, Dalmarco JB, Simionatto EL, Pizzolatti MG, Girard D, Fröde TS (2011) Protected effect of Esenbeckia leiocarpa upon the inflammatory response induced by carrageenan in a murine air pouch model. Int Immuno Pharmacol 11:1991–1999
Rittiner JE, Korboukh I, Hull-Ryde EA, Jin J, Janzen WP, Frye SV, Zylka MJ (2012) AMP is an adenosine A1 receptor agonist. J Biol Chem 287:5301–5309
Abo-Salem OM, Hayallah AM, Bilkei-Gorzo A, Filipek B, Zimmer A, Müller CE (2004) Antinociceptive effects of novel A2B adenosine receptor antagonists. J Pharmacol Exp Ther 308:358–366
Li L, Hao JX, Fredholm BB, Schulte G, Wiesenfeld-Hallin Z, Xu XJ (2010) Peripheral adenosine A2A receptors are involved in carrageenan-induced mechanical hyperalgesia in mice. Neuroscience 170:923–928
Loram LC, Taylor FR, Strand KA, Harrison JA, Rzasalynn R, Sholar P, Rieger J, Maier SF, Watkins LR (2013) Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A/PKC signaling. Brain Behav Immun 33:112–122
Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, Freeman TC (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118:1461–1468
Schulte G, Fredholm BB (2003) Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15:813–827
Souza LF, Horn AP, Gelain DP, Jardim FR, Lenz G, Bernard EA (2005) Extracellular inosine modulates ERK 1/2 and p38 phosphorylation in cultured Sertoli cells: possible participation in TNF-alpha modulation of ERK 1/2. Life Sci 77:3117–3126
Wu WP, Hao JX, Halldner L, Lövdahl C, DeLander GE, Wiesenfeld-Hallin Z, Fredholm BB, Xu XJ (2005) Increased nociceptive response in mice lacking the adenosine A1 receptor. Pain 113:395–404
Luongo F, Guida F, Imperatore R, Napolitano F, Gatta L, Cristino L, Giordano C, Siniscalco D, Di Marzo V, Bellini G, Petreli R, Cappellacci L, Usiello A, de Novelis V, Rossi F, Maione S (2014) The A1 adenosine receptor as a new player in microglia physiology. Glia 62:122–132
Vincenzi F, Targa M, Romagnoli R, Merighi S, Gessi S, Baraldi PG, Borea PA (2014) Varani. TRR469, a potent A1 adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in mice. Neuro Pharmacol 81:6–14
Sowa N, Street SE, Vihko P, Zylka MJ (2010) Prostatic acid phosphatase reduces thermal sensitivity and chronic pain sensitization by depleting phosphatidylinositol 4,5-biphosphate. J Neurosci 30:10282–10293
Carruthers AM, Sellers LA, Jenkins DW, Jarvie EM, Feniuk W, Humphrey PP (2001) Adenosine A(1) receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons. Mol Pharmacol 59:1533–1541
Lima FO, Souza GR, Verri WA Jr, Parada CA, Ferreira SH, Cunha FQ, Cunha TM (2010) Direct blockade of inflammatory hypernociception by peripheral A1 adenosine receptors: involvement of the NO/cGMP/PKG/KATP signaling pathway. Pain 151:506–515
Fredholm BB, Irenius E, Kull B, Schulte G (2001) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 61:443–448
Ibrisimovic E, Drobny H, Yang Q, Höfer T, Boehm S, Nanoff C (2012) Constitutive activity of the A2A adenosine receptor and compartmentalised cyclic AMP signalling fine-tune noradrenaline release. Purinergic Signal 8:677–692
Mediero A, Perez-Aso M, Cronstein BN (2013) Activation of adenosine A2A receptor reduces osteoclast formation via PKA- and ERK1/2-mediated suppression of NFkappaB nuclear translocation. Br J Pharmacol 169:1372–1388
Jin X, Shepherd RK, Duling BR, Linden J (1997) Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest 100:2849–2857
Keil GJ 2nd, DeLander GE (1994) Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice. Eur J Pharmacol 271:37–46
Acknowledgments
This study was supported by grants from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (FAPESC), Brazil. We wish to thank Bertil Fredholm (Karolinska Institute, Stockholm, Sweden) who supplied the initial adenosine A1R knockout mice (to JS), and whose laboratory performed polymerase chain reaction genotyping. Also, we would like to thank BioCryst Pharmaceuticals Inc. and Dr. ShantaBantia for the donation of forodesine. F.P.N., S.J.M.J., F.A.P. and A.R.S.S. thank the CNPq for their fellowship support.
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nascimento, F.P., Macedo-Júnior, S.J., Pamplona, F.A. et al. Adenosine A1 Receptor-Dependent Antinociception Induced by Inosine in Mice: Pharmacological, Genetic and Biochemical Aspects. Mol Neurobiol 51, 1368–1378 (2015). https://doi.org/10.1007/s12035-014-8815-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-014-8815-5